In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 1 to 6 of 6

TitleConsultationTypeConsultation end date
Seladelpar for previously treated primary biliary cholangitis [ID6429]Draft guidanceTechnology appraisal guidance
Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID6346]Draft guidanceTechnology appraisal guidance
Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency [ID6415]Draft guidanceTechnology appraisal guidance
Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse B-cell lymphoma [ID6202]Draft guidanceTechnology appraisal guidance
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma after 2 or more systemic treatments (review of TA677) [ID6325]Draft guidanceTechnology appraisal guidance
Dupilumab for treating severe chronic rhinosinusitis with nasal polyps (review of TA648) [ID6480]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All